Corrigendum: Evolving strategies for cancer and autoimmunity: Back to the future [Front. Immunol., 5, 154] DOI: 10.3389/fimmu.2014.00154;Evolving strategies for cancer and autoimmunity: Back to the future

Frontiers in Immunology

Volumn 5, Issue APR, 2014, Pages

  Lane, Peter J L ^a   McConnell, Fiona M ^a   Anderson, Graham ^a   Nawaf, Maher G ^a   Gaspal, Fabrina M ^a   Withers, David R ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Autoimmunity; Cancer; CD4 T cell; Keyword; Memory; Regulation; Tolerance mechanisms

Indexed keywords

CD134 ANTIGEN; CD30 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; L SELECTIN; TRANSCRIPTION FACTOR FOXP3;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; EVOLUTION; GENETIC ASSOCIATION; GENOMICS; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; INTESTINE FLORA; LYMPH NODE; MAMMAL; MONOTREMATE; NEOPLASM; NONHUMAN; PLACENTA; REGULATORY T LYMPHOCYTE; REPRODUCTION; TH17 CELL;

EID: 84900842179     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00286     Document Type: Erratum

References (68)

1. Shearer MH, Robinson ES, Vandeberg JL, Kennedy RC. Humoral immune response in a marsupial Monodelphis domestica: anti-isotypic and anti-idiotypic responses detected by species-specific monoclonal anti-immunoglobulin reagents. Dev Comp Immunol (1995) 19:237-46. doi:10.1016/0145-305X(95)00001-A.
2. Wronski EV, Woods GM, Munday BL. Antibody response to sheep red blood cells in platypus and echidna. Comp Biochem Physiol A Mol Integr Physiol (2003) 136:957-63. doi:10.1016/S1095-6433(03)00325-8.
3. Kreiss A, Wells B, Woods GM. The humoral immune response of the Tasmanian devil (Sarcophilus harrisii) against horse red blood cells. Vet Immunol Immunopathol (2009) 130:135-7. doi:10.1016/j.vetimm.2009.02.003.
4. Martin WJ. Mortality in childhood during 1920-38. Br Med J (1945) 1:363-5. doi:10.1136/bmj.1.4393.363.
5. Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer (2005) 5:615-25. doi:10.1038/nrc1669.
6. Rowe JH, Ertelt JM, Xin L, Way SS. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature (2012) 490:102-6. doi:10.1038/nature11462.
7. Warren WC, Hillier LW, Marshall Graves JA, Birney E, Ponting CP, Grutzner F, et al. Genome analysis of the platypus reveals unique signatures of evolution. Nature (2008) 453:175-83. doi:10.1038/nature06936.
8. Biggs PM. The association of lymphoid tissue with the lymph vessels in the domestic chicken (Gallus domesticus). Acta Anat (Basel) (1957) 29:36-47. doi:10.1159/000141159.
9. Diener E, Ealey EH. Immune system in a monotreme: studies on the Australian echidna (Tachyglossus aculeatus). Nature (1965) 208:950-3. doi:10.1038/208950a0.
10. Connolly JH, Canfield PJ, McClure SJ, Whittington RJ. Histological and immunohistological investigation of lymphoid tissue in the platypus (Ornithorhynchus anatinus). J Anat (1999) 195(Pt 2):161-71. doi:10.1046/j.1469-7580.1999.19520161.x.
11. Macpherson AJ, Smith K. Mesenteric lymph nodes at the center of immune anatomy. J Exp Med (2006) 203:497-500. doi:10.1084/jem.20060227.
12. Reynaud CA, Dahan A, Anquez V, Weill JC. Somatic hyperconversion diversifies the single Vh gene of the chicken with a high incidence in the D region. Cell (1989) 59:171-83. doi:10.1016/0092-8674(89)90879-9.
13. Reynaud CA, Garcia C, Hein WR, Weill JC. Hypermutation generating the sheep immunoglobulin repertoire is an antigen-independent process. Cell (1995) 80:115-25. doi:10.1016/0092-8674(95)90456-5.
14. Zhao Y, Cui H, Whittington CM, Wei Z, Zhang X, Zhang Z, et al. Ornithorhynchus anatinus (platypus) links the evolution of immunoglobulin genes in eutherian mammals and nonmammalian tetrapods. J Immunol (2009) 183:3285-93. doi:10.4049/jimmunol.0900469.
15. Tsuji M, Suzuki K, Kitamura H, Maruya M, Kinoshita K, Ivanov II, et al. Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity (2008) 29:261-71. doi:10.1016/j.immuni.2008.05.014.
16. + CD25+ regulatory T cells. Nat Immunol (2003) 4:330-6. doi:10.1038/ni904.
17. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell (2006) 126:1121-33. doi:10.1016/j.cell.2006.07.035.
18. Andersen KG, Nissen JK, Betz AG. Comparative genomics reveals key gain-of-function events in Foxp3 during regulatory T cell evolution. Front Immunol (2012) 3:113. doi:10.3389/fimmu.2012.00113.
19. + CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J Immunol (1994) 153:3764-74.
20. Tsuji M, Komatsu N, Kawamoto S, Suzuki K, Kanagawa O, Honjo T, et al. Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science (2009) 323:1488-92. doi:10.1126/science.1169152.
21. Cong Y, Feng T, Fujihashi K, Schoeb TR, Elson CO. A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. Proc Natl Acad Sci U S A (2009) 106:19256-61. doi:10.1073/pnas.0812681106.
22. Cao AT, Yao S, Gong B, Elson CO, Cong Y. Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis. J Immunol (2012) 189:4666-73. doi:10.4049/jimmunol.1200955.
23. Hirota K, Turner JE, Villa M, Duarte JH, Demengeot J, Steinmetz OM, et al. Plasticity of Th17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses. Nat Immunol (2013) 14:372-9. doi:10.1038/ni.2552.
24. Voo KS, Wang YH, Santori FR, Boggiano C, Wang YH, Arima K, et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A (2009) 106:4793-8. doi:10.1073/pnas.0900408106.
25. Canfield PJ, Hemsley S. The roles of histology and immunohistology in the investigation of marsupial disease and normal lymphoid tissue. Dev Comp Immunol (2000) 24:455-71. doi:10.1016/S0145-305X(00)00009-4.
26. Kreiss A, Obendorf DL, Hemsley S, Canfield PJ, Woods GM. A histological and immunohistochemical analysis of lymphoid tissues of the Tasmanian devil. Anat Rec (Hoboken) (2009) 292:611-20. doi:10.1002/ar.20896.
27. + CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity (1997) 7:493-504. doi:10.1016/S1074-7613(00)80371-4.
28. Kurebayashi S, Ueda E, Sakaue M, Patel DD, Medvedev A, Zhang F, et al. Retinoid-related orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis. Proc Natl Acad Sci U S A (2000) 97:10132-7. doi:10.1073/pnas.97.18.10132.
29. Sun Z, Unutmaz D, Zou YR, Sunshine MJ, Pierani A, Brenner-Morton S, et al. Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science (2000) 288:2369-73. doi:10.1126/science.288.5475.2369.
30. Futterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfeffer K. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity (1998) 9:59-70. doi:10.1016/S1074-7613(00)80588-9.
31. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature (1999) 397:315-23. doi:10.1038/16852.
32. Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Ivanov II, et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med (2009) 206:35-41. doi:10.1084/jem.20072713.
33. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity (2004) 21:241-54. doi:10.1016/j.immuni.2004.07.007.
34. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med (2008) 14:275-81. doi:10.1038/nm1710.
35. Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity (2008) 29:958-70. doi:10.1016/j.immuni.2008.11.001.
36. + )CD3(-) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells. Immunity (2003) 18:643-54. doi:10.1016/S1074-7613(03)00110-9.
37. Kim S, Han S, Withers DR, Gaspal F, Bae J, Baik S, et al. CD117(+) CD3(-) CD56(-) OX40L(high) cells express IL-22 and display an LTi phenotype in human secondary lymphoid tissues. Eur J Immunol (2011) 41:1563-72. doi:10.1002/eji.201040915.
38. Gaspal FM, Kim MY, McConnell FM, Raykundalia C, Bekiaris V, Lane PJ. Mice deficient in OX40 and CD30 signals lack memory antibody responses because of deficient CD4 T cell memory. J Immunol (2005) 174:3891-6.
39. Zinkernagel RM, Hengartner H. Protective 'immunity' by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called 'immunological memory'. Immunol Rev (2006) 211:310-9. doi:10.1111/j.0105-2896.2006.00402.x.
40. Raghavan M, Bjorkman PJ. Fc receptors and their interactions with immunoglobulins. Annu Rev Cell Dev Biol (1996) 12:181-220. doi:10.1146/annurev.cellbio.12.1.181.
41. MacLennan ICM. Germinal centers. Annu Rev Immunol (1994) 12:117-39. doi:10.1146/annurev.iy.12.040194.001001.
42. Chung Y, Tanaka S, Chu F, Nurieva RI, Martinez GJ, Rawal S, et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med (2011) 17:983-8. doi:10.1038/nm.2426.
43. Linterman MA, Pierson W, Lee SK, Kallies A, Kawamoto S, Rayner TF, et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med (2011) 17:975-82. doi:10.1038/nm.2425.
44. + thymocyte development. J Exp Med (2013) 210:675-81. doi:10.1084/jem.20122070.
45. Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol (2001) 2:1032-9. doi:10.1038/ni723.
46. Gotter J, Brors B, Hergenhahn M, Kyewski B. Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters. J Exp Med (2004) 199:155-66. doi:10.1084/jem.20031677.
47. Mathis D, Benoist C. A decade of AIRE. Nat Rev Immunol (2007) 7:645-50. doi:10.1038/nri2136.
48. O'Leary MA, Bloch JI, Flynn JJ, Gaudin TJ, Giallombardo A, Giannini NP, et al. The placental mammal ancestor and the post-K-Pg radiation of placentals. Science (2013) 339:662-7. doi:10.1126/science.1229237.
49. Rawn SM, Cross JC. The evolution, regulation, and function of placenta-specific genes. Annu Rev Cell Dev Biol (2008) 24:159-81. doi:10.1146/annurev.cellbio.24.110707.175418.
50. Tai X, Cowan M, Feigenbaum L, Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol (2005) 6:152-62. doi:10.1038/ni1160.
51. McAdam AJ, Greenwald RJ, Levin MA, Chernova T, Malenkovich N, Ling V, et al. ICOS is critical for CD40-mediated antibody class switching. Nature (2001) 409:102-5. doi:10.1038/35051107.
52. + CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med (2004) 199:1479-89. doi:10.1084/jem.20040179.
53. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol (2004) 5:266-71. doi:10.1038/ni1037.
54. Rowe JH, Ertelt JM, Aguilera MN, Farrar MA, Way SS. Foxp3(+) regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host Microbe (2011) 10:54-64. doi:10.1016/j.chom.2011.06.005.
55. Samstein RM, Josefowicz SZ, Arvey A, Treuting PM, Rudensky AY. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell (2012) 150:29-38. doi:10.1016/j.cell.2012.05.031.
56. Elahi S, Ertelt JM, Kinder JM, Jiang TT, Zhang X, Xin L, et al. Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection. Nature (2013) 504:158-62. doi:10.1038/nature12675.
57. Steinhoff MC, Omer SB, Roy E, Arifeen SE, Raqib R, Altaye M, et al. Influenza immunization in pregnancy-antibody responses in mothers and infants. N Engl J Med (2010) 362:1644-6. doi:10.1056/NEJMc0912599.
58. Gaspal F, Withers D, Saini M, Bekiaris V, McConnell FM, White A, et al. Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice. J Exp Med (2011) 208:1579-84. doi:10.1084/jem.20101484.
59. Byun M, Ma CS, Akcay A, Pedergnana V, Palendira U, Myoung J, et al. Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. J Exp Med (2013) 210(9):1743-59. doi:10.1084/jem.20130592.
60. Beard J. Embryological aspects and etiology of carcinoma. Lancet (1902) 159:1758-61. doi:10.1016/S0140-6736(01)89936-0.
61. Watson IR, Takahashi K, Futreal PA, Chin L. Emerging patterns of somatic mutations in cancer. Nat Rev Genet (2013) 14:703-18. doi:10.1038/nrg3539.
62. Malchow S, Leventhal DS, Nishi S, Fischer BI, Shen L, Paner GP, et al. Aire-dependent thymic development of tumor-associated regulatory T cells. Science (2013) 339:1219-24. doi:10.1126/science.1233913.
63. Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med (2010) 363:711-23. doi:10.1056/NEJMoa1003466.
64. Robert C, Thomas L, Bondarenko I, O'Day S, Jw MD, Garbe C, et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med (2011) 364:2517-26. doi:10.1056/NEJMoa1104621.
65. Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med (2012) 366:2443-54. doi:10.1056/NEJMoa1200690.
66. Wolchok JD, Kluger H, Callahan MK, Postow MA, Rizvi NA, Lesokhin AM, et al. Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med (2013) 369:122-33. doi:10.1056/NEJMoa1302369.
67. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity (1995) 3:541-7. doi:10.1016/1074-7613(95)90125-6.
68. Overwijk WW, Restifo NP. B16 as a mouse model for human melanoma. Curr Protoc Immunol (2001) Chapter 20(Unit 20):21. doi:10.1002/0471142735.im2001s39.